 |
|
 |
|
 |
|
 |
|
|
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
Regenetech
Kyle Shanks, President
17045 El Camino Real
Suite 101
Houston, TX 77058
Office (281) 480-8899
Cell (832) 414-9520
Fax (281) 480-4998
Copyright
2011©
All Rights Reserved
News
& Media
Regenetech, a Houston-based biotechnology company, has established a significant position as a world leader in adult stem cell technology. It has licensed 13 patents from NASA for the expansion of adult stem cells in a simulated weightless environment, and through its own research efforts has obtained several hundred patents and patent applications throughout the world. (As taken from www.HealthcareOfToday.com)
Below,
you will find some articles pertaining to the progress of
Regenetech as a company and Stem Cell research advancement.
|
Signed Joint Development Agreement with Arimed for Black Pitera cosmetic products in Southeast Asian countries. |
(2012) |
|
Signed Sales Agreement for Direct Response Marketing with Ignite Media |
(2012) |
|
Received issued botanical INCI designation |
(2011) |
|
Received issued cellXpansion INCI designation |
(2011) |
|
Regenetech
is inducted into the Space Technology Hall of Fame by the Space
Foundation for it's work on Intrifuge CellXpansion |
(March
2011) |
|
|
Regenetech
completes build-out of it's new Laboratory Facility at the El Camino
Real Office. |
(Jan 22, 2011) | |
|
Regenetech
enters into a Research Agreement with Hyalose, LLC for production
of specific biomolecules in a Simulated Microgravity System for
cosmetic applications. |
(Jan 20, 2011) | |
|
EHSI
Secures Rights To Use NASA Developed Stem Cell Technology In China
|
(Dec 30, 2010) | read more |
|
Regenetech
enters into a non-exclusive License Agreement with Emerging Healthcare
Solutions, Inc. for the expansion of Human Progenitor Cells using
Regenetech's proprietary Intrifuge System and the CellXpansion Technology. |
(Dec 23, 2010) | |
|
Emerging
Healthcare Solutions, Inc. (PinkSheets:EHSI) is negotiating a potential
option agreement with biotech firm Regenetech, Inc. |
(Dec 14, 2010) | read more |
|
Regenetech
signs new License Agreement with NASA. This Agreement entitles Regenetech
to use U.S. Patent No. 6,730,498 B1, under which the New License
field of use "shall mean the production of biomolecules and
growth factors for the use in topical applications for cosmetics
and topical treatment for burns, scars, stretch marks, acne and
joint pain." |
(Nov 9, 2010) | |
|
Regenetech,
Inc. and HealthH2O Products, LLC execute a Joint Venture Agreement
for the purpose of developing, manufacturing, marketing, and selling
topical skincare products based on Regenetech's Bio-molecules (as
defined below), produced in Regenetech's Intrifuge System using
Simulated Microgravity and H2O's current skincare products, as well
as new products that may be jointly developed. |
(Oct 16, 2010) | |
|
Regenetech
signs Letter of Intent (LOI) with Biosonex, Inc. of Manhattan Beach,
CA. The purpose of the LOI is to agree in principal to a non-exclusive
distribution agreement, where Biosonex shall have the rights to
distribute cosmetic creams produced by Regenetech to the countries
of United States, Singapore, Taiwan, Hong Kong, Mexico, India, Australia,
China, Japan and Korea. |
(Sept 7, 2010) | |
|
Notice
of Intent To Grant Exclusive License: Regenetech, Inc. |
(Aug 23, 2010) | read more |
|
Regenetech
enters into an exclusive License Agreement with Regenevita, LLC
solely for Expansion of Neo-Natal Progenitor Cells in Latin America.
Founded in 2007, Regenevita has developed alliances with the Mexican
Health Department and stem cell research experts, in order to establish
Tamaulipas as Mexico's leader in regenerative cellular therapy. |
(July 23, 2010) | |
|
Regenetech,
Inc. Announces Publication of European Patents |
(March 29, 2009) | read more |
|
Healthcare
of Today Announces $100M Acquisition of Regenetech |
(Feb 12, 2009) | read more |
|
Healthcare
Conglomerate Buys Adult Stem Cell Company in $100 Million Acquisition
|
(Feb. 6, 2009) | read more |
|
Regenetech,
Inc. of Houston, Texas and Biogenea-CellGenea, Ltd.. of Thessaloniki,
Greece jointly announce that they have entered into an extensive
technology and patent licensing agreement for Biogenea-CellGenea
to utilize Regenetech's technology for the expansion of adult stem
cells in Biogenea-CellGenea�s research and therapeutic applications
for use in Greece, Egypt ,Romania ,Bulgaria, Cyprus, Albania, and
F.Y.RO.M.. |
(Sept. 2, 2008) | read more |
|
Regenetech
And Johns Hopkins Sign Stem Cell Agreement For Diabetes |
(Nov 2007) | read more |
|
Company
Profile for Regenetech, Inc. Publication: Business |
(Oct. 19, 2007) | read more. |
|
Regenetech
Achieves a 60-Fold Increase of Adult Stem Cells Through Its cellXpansion?
Process |
(Oct. 16, 2007) | read more |
|
Studies
of adult stem cells expanded with NASA-created techniques indicate
the cells do not turn cancerous |
(May 5, 2005) | read more |
|
HOUSTON
-- Regenetech Inc., a Houston-based, adult-stem-cell company, said
today recent studies of adult stem cells expanded with its NASA-created
techniques indicate the cells do not turn cancerous. Regenetech
works with NASA under its license and a Reimbursable Space Act Agreement. |
(May 4, 2005) | read more |
|
Houston-based
REGENETECH, a biotech company, today announced a major advance in
adult stem cell research. This discovery could lead to treatment
of type-1 diabetes by converting stem cells into the insulin producing
beta cells in the pancreas to replace those damaged by diabetes. |
(March 28, 2003) | read more |
|
An Interview With David Wolf© |
||
{Trac}
